Back to Search
LEONARD LILLY, MD
MD
Cardiovascular Disease Physician
NPI: 1396735528IndividualAccepts Medicare
Specialties, Licenses & Credentials
Cardiovascular Disease PhysicianPrimary
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
44570(MA)
CMS Specialties
PrimaryCARDIOVASCULAR DISEASE (CARDIOLOGY)
Education
ALBANY MEDICAL COLLEGE OF UNION UNIVERSITY
Class of 1977
Research & Publications (20)
The difference in the fibrosis progression of recurrent hepatitis C after live donor liver transplantation versus deceased donor liver transplantation is attributable to the difference in donor age.
PMID 19025914·Liver Transpl·2008
4-observational
Liver transplantation and subsequent risk of cancer: findings from a Canadian cohort study.
PMID 18975293·Liver Transpl·2008
8-other
Sirolimus in liver transplant recipients with renal dysfunction offers no advantage over low-dose calcineurin inhibitor regimens.
PMID 18433069·Liver Transpl·2008
8-other
Survival after liver transplantation for hepatitis C is unchanged over two decades in Canada.
PMID 18299733·Can J Gastroenterol·2008
8-other
Reduced mortality with right-lobe living donor compared to deceased-donor liver transplantation when analyzed from the time of listing.
PMID 17391140·Am J Transplant·2007
8-other
Biliary strictures in 130 consecutive right lobe living donor liver transplant recipients: results of a Western center.
PMID 17227565·Am J Transplant·2007
8-other
Selective use of older adults in right lobe living donor liver transplantation.
PMID 17227563·Am J Transplant·2007
8-other
Recurrent hepatitis C post-transplantation: where are we now and where do we go from here? A report from the Canadian transplant hepatology workshop.
PMID 17111055·Can J Gastroenterol·2006
6-review
Tacrolimus as intervention in the treatment of hyperlipidemia after liver transplant.
PMID 16926593·Transplantation·2006
4-observational
De novo bone induction by recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillary sinus floor augmentation.
PMID 16297689·J Oral Maxillofac Surg·2005
3-trial
Analysis and outcomes of right lobe hepatectomy in 101 consecutive living donors.
PMID 16212638·Am J Transplant·2005
8-other
Evaluation of renal function in liver transplant recipients receiving daclizumab (Zenapax), mycophenolate mofetil, and a delayed, low-dose tacrolimus regimen vs. a standard-dose tacrolimus and mycophenolate mofetil regimen: a multicenter randomized clinical trial.
PMID 16123958·Liver Transpl·2005
3-trial
Transplant immunosuppressive agents in non-transplant chronic autoimmune hepatitis: the Canadian association for the study of liver (CASL) experience with mycophenolate mofetil and tacrolimus.
PMID 15998421·Liver Int·2005
3-trial
Randomized study evaluating recombinant human bone morphogenetic protein-2 for extraction socket augmentation.
PMID 15857102·J Periodontol·2005
3-trial
Living-donor right hepatectomy with or without inclusion of middle hepatic vein: comparison of morbidity and outcome in 56 patients.
PMID 15084170·Am J Transplant·2004
4-observational
Adefovir dipivoxil therapy for lamivudine-resistant hepatitis B in pre- and post-liver transplantation patients.
PMID 14647053·Hepatology·2003
4-observational
Successful liver transplantation using the liver of donors with cystic fibrosis.
PMID 14512894·Hepatology·2003
5-case
Outcome of patients undergoing liver transplantation for primary sclerosing cholangitis.
PMID 12907911·Dis Colon Rectum·2003
8-other
Early steroid withdrawal after liver transplantation: the Canadian tacrolimus versus microemulsion cyclosporin A trial: 1-year follow-up.
PMID 12783400·Liver Transpl·2003
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1153 CENTRE ST, SUITE 4930
JAMAICA PLAIN, MA 02130 - Phone
- (617) 983-7420
Quick Facts
- NPI
- 1396735528
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 49
- Publications
- 20
Are you this provider?
Claim Your Profile